Last reviewed · How we verify
Aminolevulinic Acid Nano Emulsion
At a glance
| Generic name | Aminolevulinic Acid Nano Emulsion |
|---|---|
| Also known as | Ameluz, Biofrontera, L01XD04, BF-200 ALA |
| Sponsor | Joint Authority for Päijät-Häme Social and Health Care |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: